Astrazeneca plc ADR (NASDAQ:AZN) traded at $75.78 at last check on Monday, April 29, made an upward move of 0.81% on its previous day’s price.
Looking at the stock we see that its previous close was $75.17. The company has a trailing 12-month PE ratio of 37.35. In terms of its 52-week price range, AZN has a high of $75.81 and a low of $60.47. The company’s stock has gained about 11.85% over that past 30 days.
Astrazeneca plc ADR has a market cap of $234.95 billion. With its Forward Dividend at 1.45 and a yield of 1.91%, the company’s investors could be anxious for the AZN stock to gain ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $1.3, with the EPS growth for the year raised at $4.54 for 2024 and $5.15 for next year. These figures represent 25.10% and 13.40% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $12.5 billion, with a low of $12.36 billion and a high of $12.7 billion. The median projection represents growth squeezing down to 14.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $51.26 billion, or 11.90% up from figures reported last year.
On the other hand, looking at the outlook for the AZN stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 50% Buy.
Looking further, we note that the PEG ratio for the AZN stock currently stands at 2.83, and the most recent price level today is 9.57% off its SMA20 and 12.82% from its 50-day simple moving average. The RSI (14) is pointing at 83.03 while the volatility over the past week is 1.40% and jumps to 1.29% over the past one month. The beta value is 0.50, while the average true range (ATR) is currently pointing at 1.25.
Coming back to Astrazeneca plc ADR (NASDAQ:AZN), we note that the average 3-month trading volume was 6.39 million. Current shares outstanding are 3.10 billion.
The insiders hold 0.03% of the company’s shares while institutions hold 16.01%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 12.52% up in year-to-date price movement.
